A. H. Conney. Pharmacological implications of microsomal enzyme induction. Pharmacol. Rev. 19(3):317–366 (1967).
PubMed
CAS
Google Scholar
R. R. Brown, J. A. Miller, and E. C. Miller. The metabolism of methylated aminoazo dyes. IV. Dietary factors enhancing demethylation in vitro. J. Biol. Chem. 209(1):211–222 (1954).
PubMed
CAS
Google Scholar
J. Y. Park, K. A. Kim, M. H. Kang, S. L. Kim, and J. G. Shin. Effect of rifampin on the pharmacokinetics of rosiglitazone in healthy subjects. Clin. Pharmacol. Ther. 75(3):157–162 (2004).
PubMed
Article
CAS
Google Scholar
S. C. Mueller, J. Majcher-Peszynska, B. Uehleke et al. The extent of induction of CYP3A by St. John’s wort varies among products and is linked to hyperforin dose. Eur. J. Clin. Pharmacol. 62(1):29–36 (2006).
PubMed
Article
CAS
Google Scholar
L. Bertilsson, B. Hojer, G. Tybring, J. Osterloh, and A. Rane. Autoinduction of carbamazepine metabolism in children examined by a stable isotope technique. Clin. Pharmacol. Ther. 27(1):83–88 (1980).
PubMed
CAS
Google Scholar
U. S. Simonsson, B. Jansson, T. N. Hai, D. X. Huong, G. Tybring, and M. Ashton. Artemisinin autoinduction is caused by involvement of cytochrome P450 2B6 but not 2C9. Clin. Pharmacol. Ther. 74(1):32–43 (2003).
PubMed
Article
CAS
Google Scholar
Multiple Prescriptions. Medical Edge Mayo Clinic; 2005.
F. J. Gonzalez. The 2006 Bernard B. Brodie award lecture. Cyp2e1. Drug Metab. Dispos. 35(1):1–8 (2007).
PubMed
Article
CAS
Google Scholar
P. Honkakoski, T. Sueyoshi, and M. Negishi. Drug-activated nuclear receptors CAR and PXR. Ann. Med. 35(3):172–182 (2003).
PubMed
Article
CAS
Google Scholar
P. K. Mandal. Dioxin: a review of its environmental effects and its aryl hydrocarbon receptor biology. J. Comp. Physiol. [B]. 175(4):221–230 (2005).
CAS
Google Scholar
L. B. Moore, J. M. Maglich, D. D. McKee et al. Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors. Mol. Endocrinol. 16(5):977–986 (2002).
PubMed
Article
CAS
Google Scholar
M. Qatanani, and D. D. Moore. CAR, the continuously advancing receptor, in drug metabolism and disease. Curr. Drug Metab. 6(4):329–339 (2005).
PubMed
Article
CAS
Google Scholar
R. G. Tirona, and R. B. Kim. Nuclear receptors and drug disposition gene regulation. J. Pharm. Sci. 94(6):1169–1186 (2005).
PubMed
Article
CAS
Google Scholar
H. Wang, and E. L. LeCluyse. Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes. Clin. Pharmacokinet. 42(15):1331–1357 (2003).
PubMed
Article
CAS
Google Scholar
G. Lemaire, C. Delescluse, M. Pralavorio, N. Ledirac, P. Lesca, and R. Rahmani. The role of protein tyrosine kinases in CYP1A1 induction by omeprazole and thiabendazole in rat hepatocytes. Life Sci. 74(18):2265–2278 (2004).
PubMed
Article
CAS
Google Scholar
Z. Zhu, S. Kim, T. Chen et al. Correlation of high-throughput pregnane X receptor (PXR) transactivation and binding assays. J. Biomol. Screen. 9(6):533–540 (2004).
PubMed
Article
CAS
Google Scholar
M. F. Yueh, M. Kawahara, and J. Raucy. High volume bioassays to assess CYP3A4-mediated drug interactions: induction and inhibition in a single cell line. Drug Metab. Dispos. 33(1):38–48 (2005).
PubMed
Article
CAS
Google Scholar
M. Sinz, S. Kim, Z. Zhu et al. Evaluation of 170 xenobiotics as transactivators of human pregnane X receptor (hPXR) and correlation to known CYP3A4 drug interactions. Curr. Drug Metab. 7(4):375–388 (2006).
PubMed
Article
CAS
Google Scholar
M. F. Yueh, M. Kawahara, and J. Raucy. Cell-based high-throughput bioassays to assess induction and inhibition of CYP1A enzymes. Toxicol In Vitro. 19(2):275–287 (2005).
PubMed
Article
CAS
Google Scholar
S. Harmsen, I. Meijerman, J. H. Beijnen, and J. H. Schellens. The role of nuclear receptors in pharmacokinetic drug-drug interactions in oncology. Cancer Treat Rev. 33(4):369–380 (2007).
PubMed
Article
CAS
Google Scholar
S. L. Ripp, J. B. Mills, O. A. Fahmi et al. Use of immortalized human hepatocytes to predict the magnitude of clinical drug-drug interactions caused by CYP3A4 induction. Drug Metab. Dispos. 34(10):1742–1748 (2006).
PubMed
Article
CAS
Google Scholar
N. J. Hewitt, R. de Kanter, and E. LeCluyse. Induction of drug metabolizing enzymes: a survey of in vitro methodologies and interpretations used in the pharmaceutical industry—do they comply with FDA recommendations? Chem. Biol. Interact. 168(1):51–65 (2007).
PubMed
Article
CAS
Google Scholar
Y. D. Gao, S. H. Olson, J. M. Balkovec et al. Attenuating pregnane X receptor (PXR) activation: a molecular modelling approach. Xenobiotica. 37(2):124–138 (2007).
PubMed
Article
CAS
Google Scholar
S. Harper, S. Avolio, B. Pacini et al. Potent inhibitors of subgenomic hepatitis C virus RNA replication through optimization of indole-N-acetamide allosteric inhibitors of the viral NS5B polymerase. J. Med. Chem. 48(14):4547–4557 (2005).
PubMed
Article
CAS
Google Scholar
M. Backlund, and M. Ingelman-Sundberg. Regulation of aryl hydrocarbon receptor signal transduction by protein tyrosine kinases. Cell Signal. 17(1):39–48 (2005).
PubMed
Article
CAS
Google Scholar
W. Hu, C. Sorrentino, M. S. Denison, K. Kolaja, and M. R. Fielden. Induction of cyp1a1 is a nonspecific biomarker of aryl hydrocarbon receptor activation: results of large scale screening of pharmaceuticals and toxicants in vivo and in vitro. Mol. Pharmacol. 71(6):1475–1486 (2007).
PubMed
Article
CAS
Google Scholar
J. B. Mills, K. A. Rose, N. Sadagopan, J. Sahi, and S. M. de Morais. Induction of drug metabolism enzymes and MDR1 using a novel human hepatocyte cell line. J. Pharmacol. Exp. Ther. 309(1):303–309 (2004).
PubMed
Article
CAS
Google Scholar
J. Sahi, G. Hamilton, M. Sinz et al. Effect of troglitazone on cytochrome P450 enzymes in primary cultures of human and rat hepatocytes. Xenobiotica. 30(3):273–284 (2000).
PubMed
Article
CAS
Google Scholar
K. Lyon, R. Faris, J. Liu et al.
Improving lot-to-lot variability and dynamic range of CYP3A4 indution in immortalized human hepatocytes (Fa2N-4 cells), Internation Society for the Study of Xenobiotics, Maui, HI, 2005.
Google Scholar
C. Aninat, A. Piton, D. Glaise et al. Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells. Drug Metab. Dispos. 34(1):75–83 (2006).
PubMed
Article
CAS
Google Scholar
A. Guillouzo, A. Corlu, C. Aninat, D. Glaise, F. Morel, and C. Guguen-Guillouzo. The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics. Chem. Biol. Interact. 168(1):66–73 (2007).
PubMed
Article
CAS
Google Scholar
W. M. Westerink and W. G. Schoonen. Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells. Toxicol In Vitro. 21:1581–1591.
M. J. Gomez-Lechon, T. Donato, R. Jover et al. Expression and induction of a large set of drug-metabolizing enzymes by the highly differentiated human hepatoma cell line BC2. Eur. J. Biochem. 268(5):1448–1459 (2001).
PubMed
Article
CAS
Google Scholar
E. L. LeCluyse, E. Alexandre, G. A. Hamilton et al. Isolation and culture of primary human hepatocytes. Methods Mol. Biol. 290:207–229 (2005).
PubMed
Google Scholar
N. J. Hewitt, M. J. Lechon, J. B. Houston et al. Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug Metab. Rev. 39(1):159–234 (2007).
PubMed
Article
CAS
Google Scholar
FDA. Guidance for industry. Drug interaction studies—study design, data analysis, and implications for dosing and labeling. Draft Guidance. 2006.
E. LeCluyse, A. Madan, G. Hamilton, K. Carroll, R. DeHaan, and A. Parkinson. Expression and regulation of cytochrome P450 enzymes in primary cultures of human hepatocytes. J. Biochem. Mol. Toxicol. 14(4):177–188 (2000).
PubMed
Article
CAS
Google Scholar
D. Runge, G. K. Michalopoulos, S. C. Strom, and D. M. Runge. Recent advances in human hepatocyte culture systems. Biochem. Biophys. Res. Commun. 274(1):1–3 (2000).
PubMed
Article
CAS
Google Scholar
H. Shih, G. V. Pickwell, D. K. Guenette, B. Bilir, and L. C. Quattrochi. Species differences in hepatocyte induction of CYP1A1 and CYP1A2 by omeprazole. Hum. Exp. Toxicol. 18(2):95–105 (1999) Feb.
PubMed
Article
CAS
Google Scholar
M. Daujat, B. Peryt, P. Lesca, G. Fourtanier, J. Domergue, and P. Maurel. Omeprazole, an inducer of human CYP1A1 and 1A2, is not a ligand for the Ah receptor. Biochem. Biophys. Res. Commun. 188(2):820–825 (1992).
PubMed
Article
CAS
Google Scholar
K. Dilger, Z. Zheng, and U. Klotz. Lack of drug interaction between omeprazole, lansoprazole, pantoprazole and theophylline. Br. J. Clin. Pharmacol. 48(3):438–444 (1999).
PubMed
Article
CAS
Google Scholar
S. Kodama, C. Koike, M. Negishi, and Y. Yamamoto. Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes. Mol. Cell. Biol. 24(18):7931–7940 (2004).
PubMed
Article
CAS
Google Scholar
J. L. Raucy. Regulation of CYP3A4 expression in human hepatocytes by pharmaceuticals and natural products. Drug Metab. Dispos. 31(5):533–539 (2003).
PubMed
Article
CAS
Google Scholar
J. L. Raucy, J. Lasker, K. Ozaki, and V. Zoleta. Regulation of CYP2E1 by ethanol and palmitic acid and CYP4A11 by clofibrate in primary cultures of human hepatocytes. Toxicol. Sci. 79(2):233–241 (2004).
PubMed
Article
CAS
Google Scholar
J. L. Raucy, L. Mueller, K. Duan, S. W. Allen, S. Strom, and J. M. Lasker. Expression and induction of CYP2C P450 enzymes in primary cultures of human hepatocytes. J. Pharmacol. Exp. Ther. 302(2):475–482 (2002).
PubMed
Article
CAS
Google Scholar
L. Schehrer, J. D. Regan, and J. Westendorf. UDS induction by an array of standard carcinogens in human and rodent hepatocytes: effect of cryopreservation. Toxicology
147(3):177–191 (2000).
PubMed
Article
CAS
Google Scholar
D. Roymans, P. Annaert, J. Van Houdt et al. Expression and induction potential of cytochromes P450 in human cryopreserved hepatocytes. Drug Metab. Dispos. 33(7):1004–1016 (2005).
PubMed
Article
CAS
Google Scholar
B. Reinach, G. de Sousa, P. Dostert, R. Ings, J. Gugenheim, and R. Rahmani. Comparative effects of rifabutin and rifampicin on cytochromes P450 and UDP-glucuronosyl-transferases expression in fresh and cryopreserved human hepatocytes. Chem. Biol. Interact. 121(1):37–48 (1999).
PubMed
Article
CAS
Google Scholar
M. Nishimura, T. Imai, Y. Morioka, S. Kuribayashi, T. Kamataki, and S. Naito. Effects of NO-1886 (Ibrolipim), a lipoprotein lipase-promoting agent, on gene induction of cytochrome P450s, carboxylesterases, and sulfotransferases in primary cultures of human hepatocytes. Drug Metab. Pharmacokinet. 19(6):422–429 (2004).
PubMed
Article
CAS
Google Scholar
E. Chung, A. N. Nafziger, D. J. Kazierad, and J. S. Bertino Jr. Comparison of midazolam and simvastatin as cytochrome P450 3A probes. Clin. Pharmacol. Ther. 79(4):350–361 (2006).
PubMed
Article
CAS
Google Scholar
J. C. Gorski, S. D. Hall, D. R. Jones, M. VandenBranden, and S. A. Wrighton. Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily. Biochem. Pharmacol. 47(9):1643–1653 (1994).
PubMed
Article
CAS
Google Scholar
T. Kronbach, D. Mathys, M. Umeno, F. J. Gonzalez, and U. A. Meyer. Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4. Mol. Pharmacol. 36(1):89–96 (1989).
PubMed
CAS
Google Scholar
S. Asimus, D. Elsherbiny, T. N. Hai et al. Artemisinin antimalarials moderately affect cytochrome P450 enzyme activity in healthy subjects. Fundam. Clin. Pharmacol. 21(3):307–316 (2007).
PubMed
Article
CAS
Google Scholar
C. Handschin, M. Podvinec, and U. A. Meyer. In silico approaches, and in vitro and in vivo experiments to predict induction of drug metabolism. Drug News Perspect. 16(7):423–434 (2003).
PubMed
Article
CAS
Google Scholar
G. Lemaire, C. Benod, V. Nahoum et al. Discovery of a highly active ligand of human pregnane X receptor: a case study from pharmacophore modeling and virtual screening to “in vivo” biological activity. Mol. Pharmacol. 72(3):572–581 (2007).
PubMed
Article
CAS
Google Scholar
R. E. Watkins, G. B. Wisely, L. B. Moore et al. The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science. 292(5525):2329–2333 (2001).
PubMed
Article
CAS
Google Scholar
P. Crivori, and I. Poggesi. Computational approaches for predicting CYP-related metabolism properties in the screening of new drugs. Eur. J. Med. Chem. 41(7):795–808 (2006).
PubMed
Article
CAS
Google Scholar
L. Xiao, X. Cui, V. Madison, R. E. White, and K. C. Cheng. Insights from a three-dimensional model into ligand binding to constitutive active receptor. Drug Metab. Dispos. 30(9):951–956 (2002).
PubMed
Article
CAS
Google Scholar
S. Ekins, C. Chang, S. Mani et al. Human pregnane X receptor antagonists and agonists define molecular requirements for different binding sites. Mol. Pharmacol. 72(3):592–603 (2007).
PubMed
Article
CAS
Google Scholar
H. Wang, H. Huang, H. Li et al. Activated pregnenolone X-receptor is a target for ketoconazole and its analogs. Clin. Cancer Res. 13(8):2488–2495 (2007).
PubMed
Article
CAS
Google Scholar
D. C. Hay, D. Zhao, A. Ross, R. Mandalam, J. Lebkowski, and W. Cui. Direct differentiation of human embryonic stem cells to hepatocyte-like cells exhibiting functional activities. Cloning Stem Cells. 9(1):51–62 (2007).
PubMed
Article
CAS
Google Scholar
M. Ek, T. Soderdahl, B. Kuppers-Munther et al. Expression of drug metabolizing enzymes in hepatocyte-like cells derived from human embryonic stem cells. Biochem. Pharmacol. 74(3):496–503 (2007).
PubMed
Article
CAS
Google Scholar
M. Ruhnke, A. K. Nussler, H. Ungefroren et al. Human monocyte-derived neohepatocytes: a promising alternative to primary human hepatocytes for autologous cell therapy. Transplantation
79(9):1097–1103 (2005).
PubMed
Article
Google Scholar
R. E. Schwartz, J. L. Linehan, M. S. Painschab, W. S. Hu, C. M. Verfaillie, and D. S. Kaufman. Defined conditions for development of functional hepatic cells from human embryonic stem cells. Stem Cells Dev. 14(6):643–655 (2005).
PubMed
Article
CAS
Google Scholar
L. Rambhatla, C. P. Chiu, P. Kundu, Y. Peng, and M. K. Carpenter. Generation of hepatocyte-like cells from human embryonic stem cells. Cell Transplant. 12(1):1–11 (2003).
PubMed
Article
Google Scholar
W. Xie, J. L. Barwick, M. Downes et al. Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature
406(6794):435–439 (2000).
PubMed
Article
CAS
Google Scholar
C. Tateno, Y. Yoshizane, N. Saito et al. Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am. J. Pathol. 165(3):901–912 (2004).
PubMed
CAS
Google Scholar
M. Katoh, T. Matsui, M. Nakajima et al.
In vivo induction of human cytochrome P450 enzymes expressed in chimeric mice with humanized liver. Drug Metab. Dispos. 33(6):754–763 (2005).
PubMed
Article
CAS
Google Scholar
M. Katoh, M. Watanabe, T. Tabata et al.
In vivo induction of human cytochrome P450 3A4 by rifabutin in chimeric mice with humanized liver. Xenobiotica
35(9):863–875 (2005).
PubMed
Article
CAS
Google Scholar
M. Nishimura, T. Yokoi, C. Tateno et al. Induction of human CYP1A2 and CYP3A4 in primary culture of hepatocytes from chimeric mice with humanized liver. Drug Metab. Pharmacokinet. 20(2):121–126 (2005).
PubMed
Article
CAS
Google Scholar
B. Carr, R. Norcross, Y. Fang et al. Characterization of the rhesus monkey CYP3A64 enzyme: species comparisons of CYP3A substrate specificity and kinetics using baculovirus-expressed recombinant enzymes. Drug Metab. Dispos. 34(10):1703–1712 (2006).
PubMed
Article
CAS
Google Scholar
T. Prueksaritanont, Y. Kuo, C. Tang et al.
In vitro and in vivo CYP3A64 induction and inhibition studies in rhesus monkeys: a preclinical approach for CYP3A-mediated drug interaction studies. Drug Metab. Dispos. 34(9):1546–1555 (2006).
PubMed
Article
CAS
Google Scholar
J. Sahi, M. W. Sinz, S. Campbell et al. Metabolism and transporter-mediated drug-drug interactions of the endothelin-A receptor antagonist CI-1034. Chem. Biol. Interact. 159(2):156–168 (2006).
PubMed
Article
CAS
Google Scholar
S. R. Faucette, T. Sueyoshi, C. M. Smith, M. Negishi, E. L. Lecluyse, and H. Wang. Differential regulation of hepatic CYP2B6 and CYP3A4 genes by constitutive androstane receptor but not pregnane X receptor. J. Pharmacol. Exp. Ther. 317(3):1200–1209 (2006).
PubMed
Article
CAS
Google Scholar
C. Handschin, and U. A. Meyer. Induction of drug metabolism: the role of nuclear receptors. Pharmacol. Rev.
55(4):649–673 (2003).
PubMed
Article
CAS
Google Scholar
K. Nakata, Y. Tanaka, T. Nakano et al. Nuclear receptor-mediated transcriptional regulation in Phase I, II, and III xenobiotic metabolizing systems. Drug Metab. Pharmacokinet. 21(6):437–457 (2006).
PubMed
Article
CAS
Google Scholar
A. Puga, A. Maier, and M. Medvedovic. The transcriptional signature of dioxin in human hepatoma HepG2 cells. Biochem. Pharmacol. 60(8):1129–1142 (2000).
PubMed
Article
CAS
Google Scholar
S. P. Rivera, S. T. Saarikoski, and O. Hankinson. Identification of a novel dioxin-inducible cytochrome P450. Mol. Pharmacol. 61(2):255–259 (2002).
PubMed
Article
CAS
Google Scholar
M. Runge-Morris, and T. Kocarek. Regulation of sulfotransferases by xenobiotic receptors. Curr. Drug Metab. 6(4):299–307 (2005).
PubMed
Article
CAS
Google Scholar
J. Zhou, J. Zhang, and W. Xie. Xenobiotic nuclear receptor-mediated regulation of UDP-glucuronosyl-transferases. Curr. Drug Metab. 6(4):289–298 (2005).
PubMed
Article
CAS
Google Scholar
G. T. Tucker, J. B. Houston, and S. M. Huang. Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential--toward a consensus. Pharm. Res. 18(8):1071–1080 (2001).
PubMed
Article
CAS
Google Scholar